Hims & Hers Expands Into Canada After Buying Local Health Platform Livewell

Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent completion of Hims & Hers' acquisition of Livewell, a trusted Canadian digital health platform offering access to a variety of treatments, with a focus on weight loss. Building on a strong foundation in both the US and Europe, the entry into Canada positions Hims & Hers to lead the next era of digital health, centered on providing access to customer-first, affordable, and personalized care.

Building on a strong foundation in both the US and Europe, the entry into Canada positions Hims & Hers to lead the next era of digital health, centered on providing access to customer-first, affordable, and personalized care.

This strategic move is expected to help accelerate the launch of Hims & Hers' comprehensive weight loss program in Canada next year, timed to align with the first anticipated availability of generic semaglutide anywhere in the world. Almost two-thirds of adults in Canada are overweight or living with obesity, yet access to effective, proven treatments remains limited due to high costs and barriers to care. Livewell's strong local presence and Hims & Hers' innovative platform will help make personalized, high-quality care more accessible to a broader Canadian audience.

To best serve its new Canadian customers, Hims & Hers has established dedicated local leadership. Canadian business leader Austin Kouri will take the helm in-market as the General Manager of Canada, working closely with Hims & Hers' advisor and new Chief Medical Officer in Canada, Dr. Sandy Van, MD, CCFP, ABOM Dipl, a leading Obesity Physician. This underscores the company's commitment to localized leadership, understanding, and specialized medical expertise.